speb/financial-data huggingface dataset:
Financial ratios for CLPR — annual report dated 2022-12-31
Total revenue: 129746000
Gross profit: 67879000
Operating income: 28142000
Net income: -4764000
Capital expenditures: 0
Operating cash flow: 20139000
Depreciation & amortization: 26985000
Net tangible assets: 7818000
Owner earnings: 22221000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.68
Shares outstanding: 16157566
Book value: 37179000
P/B ratio: 2.0338741999515855
Market cap (USD): 75617408.88
Debt to equity: 31.243605261034453
Current ratio: 2.8855153855153857
Quick ratio: 2.8855153855153857
Interest coverage ratio: 0.6999278732559007
COGS to revenue (%): 47.86891310714781
SG&A to revenue (%): 9.828434017233672
Free cash flow (dilution-adjusted): 17219000
Buyback yield (%): 0
Retained earnings: -74895000
Receivables turnover: 25.92327672327672
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.320918866805714
FCF margin (%): 13.271314722611871
Rule of 40 score: 13.271314722611871
Financial ratios for CLPR — annual report dated 2023-12-31
Total revenue: 138205000
Gross profit: 75635000
Operating income: 33527000
Net income: -5900000
Capital expenditures: 0
Operating cash flow: 26185000
Depreciation & amortization: 28939000
Net tangible assets: -3035000
Owner earnings: 23039000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.23
Shares outstanding: 16157566
Book value: 7235000
P/B ratio: 9.446648815480305
Market cap (USD): 68346504.18
Debt to equity: 166.63773324118867
Current ratio: 2.489282652186339
Quick ratio: 2.489282652186339
Interest coverage ratio: 0.7472529921768784
COGS to revenue (%): 45.36883614919866
SG&A to revenue (%): 9.528598820592597
Free cash flow (dilution-adjusted): 23170000
Buyback yield (%): 0
Retained earnings: -86899000
Receivables turnover: 26.675352248600657
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.729464902111474
FCF margin (%): 16.764950616837307
Revenue growth (%): 6.519661492454489
Rule of 40 score: 23.284612109291796
Financial ratios for CLPR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.78
Shares outstanding: 16157566
Market cap (USD): 77233165.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLPR — annual report dated 2024-12-31
Total revenue: 148775000
Gross profit: 84842000
Operating income: 40798000
Net income: -2500000
Capital expenditures: 0
Operating cash flow: 31862000
Depreciation & amortization: 29892000
Net tangible assets: -10737000
Owner earnings: 27392000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.9
Shares outstanding: 16157566
Book value: -14230000
Market cap (USD): 63014507.4
Debt to equity: -88.99086437104708
Current ratio: 2.7042336234050506
Quick ratio: 2.7042336234050506
Interest coverage ratio: 0.8659973254653902
COGS to revenue (%): 43.044194253066706
SG&A to revenue (%): 9.512350865400773
Free cash flow (dilution-adjusted): 29161000
Buyback yield (%): 0
Retained earnings: -95507000
Receivables turnover: 23.373919874312648
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2169142287622
FCF margin (%): 19.600739371534196
Revenue growth (%): 7.648059042726385
Rule of 40 score: 27.24879841426058
Financial ratios for CLPR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.9
Shares outstanding: 16157566
Market cap (USD): 63014507.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLPR — quarterly report dated 2025-03-31
Total revenue: 39398000
Gross profit: 21660000
Operating income: 10199000
Net income: -13347000
Capital expenditures: 0
Operating cash flow: 6676000
Depreciation & amortization: 7636000
Net tangible assets: -25288000
Owner earnings: -5711000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.35
Shares outstanding: 16157566
Book value: -52804000
Market cap (USD): 54127846.1
Debt to equity: -24.10624195136732
Current ratio: 5.097155071504911
Quick ratio: 5.097155071504911
Interest coverage ratio: 0.8851761846901579
COGS to revenue (%): 45.08604497690238
SG&A to revenue (%): 9.708614650489872
Free cash flow (dilution-adjusted): 5533000
Buyback yield (%): 0
Retained earnings: -110388000
Receivables turnover: 5.649268712360195
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8208886749718697
FCF margin (%): 14.043860094421037
Rule of 40 score: 14.043860094421037
Financial ratios for CLPR — quarterly report dated 2025-06-30
Total revenue: 39036000
Gross profit: 21957000
Operating income: 10824000
Net income: -516000
Capital expenditures: 0
Operating cash flow: 8368000
Depreciation & amortization: 7314000
Net tangible assets: -27053000
Owner earnings: 6798000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.28
Shares outstanding: 16157566
Book value: -57696000
Market cap (USD): 52996816.48
Debt to equity: -21.980223932334997
Current ratio: 4.945905675045348
Quick ratio: 4.945905675045348
Interest coverage ratio: 0.9429392804251241
COGS to revenue (%): 43.81596475048673
SG&A to revenue (%): 9.78327697509991
Free cash flow (dilution-adjusted): 7290000
Buyback yield (%): 0
Retained earnings: -112438000
Receivables turnover: 4.977177100599261
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.88295250704184
FCF margin (%): 18.67506916692284
Revenue growth (%): -0.9188283669221787
Rule of 40 score: 17.75624080000066
Financial ratios for CLPR — quarterly report dated 2025-09-30
Total revenue: 37698000
Gross profit: 20589000
Operating income: 8895000
Net income: -1751000
Capital expenditures: 0
Operating cash flow: 1420000
Depreciation & amortization: 7997000
Net tangible assets: -30129000
Owner earnings: 6246000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.48
Shares outstanding: 16157566
Book value: -65840000
Market cap (USD): 56228329.68
Debt to equity: -19.336087484811664
Current ratio: 5.451741861793261
Quick ratio: 5.451741861793261
Interest coverage ratio: 0.6677927927927928
COGS to revenue (%): 45.45333969971882
SG&A to revenue (%): 9.806886306965886
Free cash flow (dilution-adjusted): 343000
Buyback yield (%): 0
Retained earnings: -115723000
Receivables turnover: 4.992451330949543
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7267406234527656
FCF margin (%): 0.9098625921799565
Revenue growth (%): -3.427605287426991
Rule of 40 score: -2.5177426952470343
Financial ratios for CLPR — annual report dated 2025-12-31
Total revenue: 153202000
Gross profit: 84822000
Operating income: 37972000
Net income: -19900000
Capital expenditures: 0
Operating cash flow: 22571000
Depreciation & amortization: 31327000
Net tangible assets: -35684000
Owner earnings: 11427000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.59
Shares outstanding: 16157566
Book value: -80754000
Market cap (USD): 58005661.94
Debt to equity: -15.819909849666889
Current ratio: 4.309971258014592
Quick ratio: 4.309971258014592
Interest coverage ratio: 0.7160880306259075
COGS to revenue (%): 44.69980809650004
SG&A to revenue (%): 10.13237425098889
Free cash flow (dilution-adjusted): 18305000
Buyback yield (%): 0
Retained earnings: -121543000
Receivables turnover: 17.658137390502535
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1221145394733054
FCF margin (%): 11.948277437631361
Revenue growth (%): 2.975634347168543
Rule of 40 score: 14.923911784799905
Financial ratios for CLPR — quarterly report dated 2025-12-31
Total revenue: 37070000
Gross profit: 20616000
Operating income: 8054000
Net income: -4285000
Capital expenditures: 0
Operating cash flow: 6107000
Depreciation & amortization: 8380000
Net tangible assets: -35684000
Owner earnings: 4095000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.59
Shares outstanding: 16157566
Book value: -80754000
Market cap (USD): 58005661.94
Debt to equity: -15.819909849666889
Current ratio: 4.309971258014592
Quick ratio: 4.309971258014592
Interest coverage ratio: 0.4821022387166288
COGS to revenue (%): 44.453736174804426
SG&A to revenue (%): 11.281359589964932
Free cash flow (dilution-adjusted): 5139000
Buyback yield (%): 0
Retained earnings: -121543000
Receivables turnover: 4.272706316274781
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.662211906165543
FCF margin (%): 13.862961963852172
Revenue growth (%): -1.6658708684810866
Rule of 40 score: 12.197091095371086
Financial ratios for CPG.L — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.18783783783783786
Shares outstanding: 1700313227
Market cap (USD): 319383160.2067568
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPG.L — annual report dated 2022-09-30
Total revenue: 31654569142.011112
Gross profit: 10293442521.244446
Operating income: 1964141696.1333332
Net income: 1385942055.9555554
Capital expenditures: 303989081.21111107
Operating cash flow: 1980271729.011111
Depreciation & amortization: 905763384.8222222
Net tangible assets: -1506666666.6666667
Owner earnings: 1987716359.5666666
Return on net tangible assets (%): -131.92807696238938
Capex to operating income (%): 15.476942514358964
Buffett classification: The Great
Stock price: 0.18533333333333332
P/E ratio: 0.2273722171259172
Shares outstanding: 1700313227
Book value: 7323333333.333332
P/B ratio: 0.04303023005061448
Market cap (USD): 315124718.0706667
Debt to equity: 0.8259748141404947
Current ratio: 0.9504584819154356
Quick ratio: 0.8778655119714722
Effective tax rate (%): 23.96187882922427
Interest coverage ratio: 12.86991869878686
COGS to revenue (%): 67.48196926934516
SG&A to revenue (%): 0.027438068366235264
Free cash flow (dilution-adjusted): 1368571251.311111
Buyback yield (%): 167.3394588782648
Retained earnings: 361111111.1111111
Inventory turnover: 33.72809466435087
Receivables turnover: 6.399171659436209
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.518870652493117
FCF margin (%): 4.3234556287003105
Rule of 40 score: 4.3234556287003105
Financial ratios for CPG.L — annual report dated 2023-09-30
Total revenue: 46228048780.48781
Gross profit: 15048780487.804878
Operating income: 3131707317.073171
Net income: 1965853658.5365856
Capital expenditures: 447560975.6097561
Operating cash flow: 3092682926.8292685
Depreciation & amortization: 1160975609.7560976
Net tangible assets: -2831707317.073171
Owner earnings: 2679268292.682927
Return on net tangible assets (%): -94.6167097329888
Capex to operating income (%): 14.291277258566975
Buffett classification: The Great
Stock price: 0.22963414634146342
P/E ratio: 0.19861599295539703
Shares outstanding: 1700313227
Book value: 7682926829.268291
P/B ratio: 0.05082047311811112
Market cap (USD): 390449976.39524394
Debt to equity: 0.8360317460317462
Current ratio: 0.7458154506437767
Quick ratio: 0.6715665236051502
Effective tax rate (%): 24.567150210575576
Interest coverage ratio: 11.619909502262445
COGS to revenue (%): 67.44664573825415
SG&A to revenue (%): 0.026380351913894526
Free cash flow (dilution-adjusted): 2163414634.146342
Buyback yield (%): 358.5606568414313
Retained earnings: 1241463414.6341465
Inventory turnover: 36.94653179190751
Receivables turnover: 10.151847884306374
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.113212200937273
FCF margin (%): 4.67987442952489
Revenue growth (%): 46.03910283250438
Rule of 40 score: 50.71897726202927
Financial ratios for CPG.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -4526666666.666667
Buffett classification: The Gruesome
Stock price: 0.3066666666666667
Shares outstanding: 1700313227
Book value: 9208000000
P/B ratio: 0.05662786594410658
Market cap (USD): 521429389.6133334
Debt to equity: 0.8559223863307268
Current ratio: 0.7439436060365369
Quick ratio: 0.6710683081810961
Buyback yield (%): 0
Retained earnings: 2098666666.6666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPG.L — annual report dated 2024-09-30
Total revenue: 56002666666.666664
Gross profit: 18568000000
Operating income: 3930666666.6666665
Net income: 1885333333.3333333
Capital expenditures: 654666666.6666666
Operating cash flow: 4180000000
Depreciation & amortization: 1400000000
Net tangible assets: -4526666666.666667
Owner earnings: 2630666666.6666665
Return on net tangible assets (%): -58.114874815905736
Capex to operating income (%): 16.655359565807327
Buffett classification: The Great
Stock price: 0.3066666666666667
P/E ratio: 0.27657145842291375
Shares outstanding: 1700313227
Book value: 9208000000
P/B ratio: 0.05662786594410658
Market cap (USD): 521429389.6133334
Debt to equity: 0.8559223863307268
Current ratio: 0.7439436060365369
Quick ratio: 0.6710683081810961
Effective tax rate (%): 31.22568093385214
Interest coverage ratio: 9.665573770491802
COGS to revenue (%): 66.84443597923908
SG&A to revenue (%): 0.02618922908432932
Free cash flow (dilution-adjusted): 2888000000
Buyback yield (%): 147.5431474823146
Retained earnings: 2098666666.6666667
Inventory turnover: 38.25068119891008
Receivables turnover: 10.147861802367721
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.64859564334244
FCF margin (%): 5.156897290605209
Revenue growth (%): 21.144344492222178
Rule of 40 score: 26.301241782827386
Financial ratios for CPG.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: -5471428571.428572
Buffett classification: The Gruesome
Stock price: 0.3223376623376623
Shares outstanding: 1700313227
Book value: 9158441558.441559
P/B ratio: 0.059843695822660234
Market cap (USD): 548074990.832987
Debt to equity: 1.009075439591605
Current ratio: 0.6888186634445581
Quick ratio: 0.6166930012082908
Buyback yield (%): 0
Retained earnings: 2174025974.025974
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPG.L — annual report dated 2025-09-30
Total revenue: 62256756756.75676
Gross profit: 20801351351.351353
Operating income: 4452702702.7027025
Net income: 2540540540.5405407
Capital expenditures: 645945945.945946
Operating cash flow: 4548648648.648648
Depreciation & amortization: 1608108108.108108
Net tangible assets: -5450000000
Owner earnings: 3502702702.7027025
Return on net tangible assets (%): -64.26977436151748
Capex to operating income (%): 14.506828528072838
Buffett classification: The Great
Stock price: 0.3344594594594595
P/E ratio: 0.2238444274906915
Shares outstanding: 1700313227
Book value: 10486486486.486485
P/B ratio: 0.0542303509900129
Market cap (USD): 568685842.8141892
Debt to equity: 0.9010309278350518
Current ratio: 0.7307079231129864
Quick ratio: 0.653820909517112
Effective tax rate (%): 27.24458204334365
Interest coverage ratio: 8.716931216931217
COGS to revenue (%): 66.58780117212936
Free cash flow (dilution-adjusted): 3232432432.432432
Buyback yield (%): 27.327109927050202
Retained earnings: 3110810810.810811
Inventory turnover: 37.4109756097561
Receivables turnover: 10.080962800875275
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.529595015576326
FCF margin (%): 5.192098979813327
Revenue growth (%): 11.167486232959316
Rule of 40 score: 16.359585212772643
Financial ratios for CPG.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: -5450000000
Buffett classification: The Gruesome
Stock price: 0.3344594594594595
Shares outstanding: 1700313227
Book value: 10486486486.486485
P/B ratio: 0.0542303509900129
Market cap (USD): 568685842.8141892
Debt to equity: 0.9010309278350518
Current ratio: 0.7307079231129864
Quick ratio: 0.653820909517112
Buyback yield (%): 0
Retained earnings: 3110810810.810811
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 47.59
Shares outstanding: 668200216
Market cap (USD): 31799648279.440002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRH — annual report dated 2022-12-31
Total revenue: 34811702127.65958
Gross profit: 11505319148.93617
Operating income: 3998936170.212766
Net income: 4137234042.5531917
Capital expenditures: 1620212765.9574468
Operating cash flow: 4042553191.489362
Depreciation & amortization: 1677659574.4680853
Net tangible assets: 12627659574.468086
Owner earnings: 4194680851.0638294
Return on net tangible assets (%): 33.21819713563605
Capex to operating income (%): 40.516094706038835
Buffett classification: The Good
Stock price: 36.98
P/E ratio: 5.972599986736744
Shares outstanding: 668200216
Book value: 24510638297.87234
P/B ratio: 1.0081354751918055
Market cap (USD): 24710043987.679996
Debt to equity: 0.4719618055555555
Current ratio: 1.8446710608133319
Quick ratio: 1.3230941425195872
Effective tax rate (%): 22.016758162380814
Interest coverage ratio: 10.92732558139535
COGS to revenue (%): 66.94985178620541
SG&A to revenue (%): 21.562815145310637
Free cash flow (dilution-adjusted): 2314893617.021277
Buyback yield (%): 5.071587448353075
Retained earnings: 23930851063.82979
Inventory turnover: 5.223652837386743
Receivables turnover: 8.356230847803882
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.083695477225172
FCF margin (%): 6.649757051615072
Rule of 40 score: 6.649757051615072
Financial ratios for CRH — annual report dated 2023-12-31
Total revenue: 38832222222.22222
Gross profit: 13292222222.222221
Operating income: 4985555555.555555
Net income: 3504444444.444444
Capital expenditures: 2018888888.8888888
Operating cash flow: 5574444444.444445
Depreciation & amortization: 1814444444.4444444
Net tangible assets: 11838888888.88889
Owner earnings: 3299999999.9999995
Return on net tangible assets (%): 27.87423744720788
Capex to operating income (%): 40.49476264764876
Buffett classification: The Good
Stock price: 67.05
P/E ratio: 12.784572617159162
Shares outstanding: 668200216
Book value: 24023333333.33333
P/B ratio: 1.864971187018177
Market cap (USD): 44802824482.799995
Debt to equity: 0.6022848156884512
Current ratio: 1.6863077998601819
Quick ratio: 1.2577649056226905
Effective tax rate (%): 23.04434479322372
Interest coverage ratio: 11.933510638297872
COGS to revenue (%): 65.77012217803085
SG&A to revenue (%): 20.9934475950671
Free cash flow (dilution-adjusted): 3418888888.888889
Buyback yield (%): 7.606167283239115
Retained earnings: 25464444444.444443
Inventory turnover: 5.356793288277791
Receivables turnover: 9.778679350867375
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.979389149935926
FCF margin (%): 8.804257632550287
Revenue growth (%): 11.54933499033978
Rule of 40 score: 20.35359262289007
Financial ratios for CRH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 91.04
Shares outstanding: 668200216
Market cap (USD): 60832947664.64001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRH — annual report dated 2024-12-31
Total revenue: 37054166666.66667
Gross profit: 13230208333.333334
Operating income: 5127083333.333334
Net income: 3667708333.3333335
Capital expenditures: 2685416666.666667
Operating cash flow: 5196875000
Depreciation & amortization: 1872916666.6666667
Net tangible assets: 9723958333.333334
Owner earnings: 2855208333.333333
Return on net tangible assets (%): 29.36261381896089
Capex to operating income (%): 52.37708248679399
Buffett classification: The Good
Stock price: 91.15
P/E ratio: 16.606132263806874
Shares outstanding: 668200216
Book value: 23802083333.333332
P/B ratio: 2.558870533954661
Market cap (USD): 60906449688.4
Debt to equity: 0.6811378555798687
Current ratio: 1.367812742812743
Quick ratio: 0.9059829059829061
Effective tax rate (%): 23.016546457361052
Interest coverage ratio: 8.04248366013072
COGS to revenue (%): 64.29495108512313
SG&A to revenue (%): 21.44102102777465
Free cash flow (dilution-adjusted): 2381250000
Buyback yield (%): 2.534624835133046
Retained earnings: 25037500000
Inventory turnover: 4.8098843322818094
Receivables turnover: 9.290154087229043
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.208249621747651
FCF margin (%): 6.426402788710221
Revenue growth (%): -4.578814844487667
Rule of 40 score: 1.8475879442225542
Financial ratios for CRH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 91.15
Shares outstanding: 668200216
Market cap (USD): 60906449688.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRH — quarterly report dated 2025-03-31
Total revenue: 7343478260.869565
Gross profit: 1996739130.4347825
Operating income: 4347826.0869565215
Net income: -102173913.04347825
Capital expenditures: 663043478.2608695
Operating cash flow: -716304347.8260869
Depreciation & amortization: 518478260.8695652
Net tangible assets: 9169565217.391304
Owner earnings: -246739130.43478256
Return on net tangible assets (%): -2.690848743480322
Capex to operating income (%): 15250
Buffett classification: The Gruesome
Stock price: 87
Shares outstanding: 668200216
Book value: 24301086956.52174
P/B ratio: 2.3922147554967124
Market cap (USD): 58133418792
Debt to equity: 0.760075144250123
Current ratio: 1.63475665748393
Quick ratio: 1.065426997245179
Interest coverage ratio: 0.022099447513812154
COGS to revenue (%): 72.80935464772054
SG&A to revenue (%): 27.131438721136767
Free cash flow (dilution-adjusted): -1452173913.0434783
Buyback yield (%): 0.5796261921989362
Retained earnings: 25407608695.652172
Inventory turnover: 0.9917338709677418
Receivables turnover: 1.6032273374466066
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.009257330648707445
FCF margin (%): -19.775014801657786
Rule of 40 score: -19.775014801657786
Financial ratios for CRH — quarterly report dated 2025-06-30
Total revenue: 12007058823.529411
Gross profit: 4736470588.235294
Operating income: 2242352941.1764708
Net income: 1567058823.5294118
Capital expenditures: 735294117.6470588
Operating cash flow: 1621176470.5882354
Depreciation & amortization: 621176470.5882353
Net tangible assets: 11097647058.82353
Owner earnings: 1452941176.4705882
Return on net tangible assets (%): 13.092335418212656
Capex to operating income (%): 32.791185729275966
Buffett classification: The Good
Stock price: 91.15
P/E ratio: 41.57763470182516
Shares outstanding: 668200216
Book value: 27800000000
P/B ratio: 2.1908794851942446
Market cap (USD): 60906449688.4
Debt to equity: 0.7260262378332628
Current ratio: 1.7447029018885307
Quick ratio: 1.1630584983878398
Effective tax rate (%): 24.202733485193622
Interest coverage ratio: 9.53
COGS to revenue (%): 60.55261610817166
SG&A to revenue (%): 20.77209484616892
Free cash flow (dilution-adjusted): 810588235.2941177
Buyback yield (%): 0.645155280731174
Retained earnings: 28360000000
Inventory turnover: 1.223520095030687
Receivables turnover: 1.9162598573037926
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.2075055187637975
FCF margin (%): 6.7509308250049
Revenue growth (%): 63.50642566085048
Rule of 40 score: 70.25735648585538
Financial ratios for CRH — quarterly report dated 2025-09-30
Total revenue: 13022352941.176472
Gross profit: 5069411764.705882
Operating income: 2318823529.4117646
Net income: 1787058823.5294118
Capital expenditures: 557647058.8235295
Operating cash flow: 2342352941.1764708
Depreciation & amortization: 707058823.5294118
Net tangible assets: 9984705882.352942
Owner earnings: 1936470588.235294
Return on net tangible assets (%): 19.394367856722045
Capex to operating income (%): 24.048706240487068
Buffett classification: The Great
Stock price: 119.05
P/E ratio: 24.462057840274
Shares outstanding: 668200216
Book value: 28975294117.647064
P/B ratio: 2.7454159875585686
Market cap (USD): 79549235714.8
Debt to equity: 0.838564294124812
Current ratio: 1.4532597447395652
Quick ratio: 1.020438082097275
Effective tax rate (%): 22.280062467464862
Interest coverage ratio: 9.430622009569378
COGS to revenue (%): 61.0714608365706
SG&A to revenue (%): 21.122052579275454
Free cash flow (dilution-adjusted): 1601176470.5882351
Buyback yield (%): 0.42297149081558594
Retained earnings: 29491764705.882355
Inventory turnover: 1.3468818489738992
Receivables turnover: 1.9622407374578976
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.199782659649272
FCF margin (%): 12.295600325232629
Revenue growth (%): 8.455810307662173
Rule of 40 score: 20.751410632894803
Financial ratios for CRH — quarterly report dated 2025-12-31
Total revenue: 11077647058.82353
Gross profit: 3948235294.117647
Operating income: 1696470588.235294
Net income: 1220000000
Capital expenditures: 965882352.9411765
Operating cash flow: 3429411764.7058825
Depreciation & amortization: 647058823.5294118
Net tangible assets: 10420000000
Owner earnings: 901176470.5882353
Return on net tangible assets (%): 8.648526589138534
Capex to operating income (%): 56.934812760055486
Buffett classification: The Good
Stock price: 123.91
P/E ratio: 18.514698236200097
Shares outstanding: 668200216
Book value: 29974117647.05883
P/B ratio: 2.7622727627708605
Market cap (USD): 82796688764.56
Debt to equity: 0.7734123557579087
Current ratio: 1.7425177061914554
Quick ratio: 1.1426776330820199
Effective tax rate (%): 19.309262166405023
Interest coverage ratio: 6.554545454545455
COGS to revenue (%): 64.35853865760407
SG&A to revenue (%): 18.288020390824126
Free cash flow (dilution-adjusted): 2417647058.8235297
Buyback yield (%): 0.35664967047988455
Retained earnings: 30109411764.705883
Inventory turnover: 1.1540658922110074
Receivables turnover: 2.191806331471136
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9087241553202214
FCF margin (%): 21.824553950722176
Revenue growth (%): -14.933598337699882
Rule of 40 score: 6.890955613022294
Financial ratios for CRH — annual report dated 2025-12-31
Total revenue: 44055294117.64706
Gross profit: 15915294117.647058
Operating income: 6262352941.176471
Net income: 4458823529.411765
Capital expenditures: 3191764705.882353
Operating cash flow: 6617647058.823529
Depreciation & amortization: 2536470588.2352943
Net tangible assets: 10420000000
Owner earnings: 3803529411.7647066
Return on net tangible assets (%): 36.50220164841369
Capex to operating income (%): 50.967499530340035
Buffett classification: The Good
Stock price: 123.91
P/E ratio: 18.56917821896464
Shares outstanding: 668200216
Book value: 29974117647.05883
P/B ratio: 2.7622727627708605
Market cap (USD): 82796688764.56
Debt to equity: 0.7734123557579087
Current ratio: 1.7425177061914554
Quick ratio: 1.1426776330820199
Effective tax rate (%): 21.664932362122787
Interest coverage ratio: 6.571604938271605
COGS to revenue (%): 63.87427564290865
SG&A to revenue (%): 21.398242849894515
Free cash flow (dilution-adjusted): 3257647058.8235292
Buyback yield (%): 1.6781006407838392
Retained earnings: 30109411764.705883
Inventory turnover: 4.555132355741764
Receivables turnover: 8.71671322160149
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.737266767523954
FCF margin (%): 7.394450823831014
Revenue growth (%): 18.894305501352658
Rule of 40 score: 26.288756325183673
Financial ratios for CYN.L — annual report dated 2021-06-30
Total revenue: 74562500
Net income: 73733333.33333334
Capital expenditures: 0
Operating cash flow: 2022222.2222222222
Net tangible assets: 160165277.7777778
Owner earnings: 73733333.33333334
Return on net tangible assets (%): 46.03577901299873
Buffett classification: The Gruesome
Stock price: 0.017777777777777778
P/E ratio: 0.008721696925858951
Shares outstanding: 36173238
Book value: 160165277.7777778
P/B ratio: 0.00401510112297193
Market cap (USD): 643079.7866666666
Debt to equity: 0.13874556664556578
Effective tax rate (%): 0.2067746907778488
COGS to revenue (%): 0
SG&A to revenue (%): 0.8736146037068081
Free cash flow (dilution-adjusted): 2022222.2222222222
Buyback yield (%): 0
Receivables turnover: 394.7426470588235
Capitalized R&D asset: 0
FCF margin (%): 2.712116978671882
Rule of 40 score: 2.712116978671882
Financial ratios for CYN.L — annual report dated 2022-06-30
Total revenue: 29574390.24390244
Net income: 28657317.073170733
Capital expenditures: 0
Net tangible assets: 164721951.2195122
Owner earnings: 28657317.073170733
Return on net tangible assets (%): 17.397388059701495
Buffett classification: The Gruesome
Stock price: 0.0175609756097561
P/E ratio: 0.022166672079662966
Shares outstanding: 36173238
Book value: 164721951.21951222
P/B ratio: 0.003856421961620469
Market cap (USD): 635237.3502439025
Debt to equity: 0.12585880123193555
Effective tax rate (%): 0.8522847137251592
COGS to revenue (%): 0
SG&A to revenue (%): 2.267947713496351
Free cash flow (dilution-adjusted): 2963414.6341463416
Buyback yield (%): 0
Capitalized R&D asset: 0
FCF margin (%): 10.020205352356603
Revenue growth (%): -60.33610696542841
Rule of 40 score: -50.3159016130718
Financial ratios for CYN.L — annual report dated 2023-06-30
Total revenue: 8144303.797468354
Net income: 6625316.455696202
Capital expenditures: 0
Net tangible assets: 172860759.49367088
Owner earnings: 6625316.455696202
Return on net tangible assets (%): 3.8327475102519033
Buffett classification: The Gruesome
Stock price: 0.01822784810126582
P/E ratio: 0.09952132732136033
Shares outstanding: 36173238
Book value: 172860759.49367088
P/B ratio: 0.0038144011950790855
Market cap (USD): 659360.2875949366
Debt to equity: 0.11716461628588166
Effective tax rate (%): 8.624301675977652
COGS to revenue (%): 0
SG&A to revenue (%): 10.972956170345041
Free cash flow (dilution-adjusted): 6744303.797468354
Buyback yield (%): 0
Receivables turnover: 643.4
Capitalized R&D asset: 0
FCF margin (%): 82.81007149518184
Revenue growth (%): -72.46163410199972
Rule of 40 score: 10.348437393182124
Financial ratios for CYN.L — annual report dated 2024-06-30
Total revenue: 13370886.075949367
Net income: 11551898.734177215
Capital expenditures: 0
Net tangible assets: 175400000
Owner earnings: 11551898.734177215
Return on net tangible assets (%): 6.586031205346189
Buffett classification: The Gruesome
Stock price: 0.021265822784810123
P/E ratio: 0.06659110216962523
Shares outstanding: 36173238
Book value: 175400000
P/B ratio: 0.004385710768875481
Market cap (USD): 769253.6688607594
Debt to equity: 0.12268521859619241
Effective tax rate (%): 5.115408608858391
COGS to revenue (%): 0
SG&A to revenue (%): 8.889520022720818
Free cash flow (dilution-adjusted): 4943037.974683544
Buyback yield (%): 225.10722271689207
Receivables turnover: 310.6764705882353
Capitalized R&D asset: 0
FCF margin (%): 36.968664205244714
Revenue growth (%): 64.17469692259871
Rule of 40 score: 101.14336112784343
Financial ratios for CYN.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 153313750
Buffett classification: The Gruesome
Stock price: 0.021124999999999998
Shares outstanding: 36173238
Book value: 153313750
P/B ratio: 0.004984286489307058
Market cap (USD): 764159.6527499999
Debt to equity: 0.10599179786548825
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EML.V — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 109
Buffett classification: The Gruesome
Stock price: 0.25984251968503935
Shares outstanding: 201883424
Market cap (USD): 52457897.574803144
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EML.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -1717
Operating income: -1914819
Net income: -1928042
Capital expenditures: 703005
Operating cash flow: -1673597
Depreciation & amortization: 2232
Net tangible assets: 4061387
Owner earnings: -2628815
Return on net tangible assets (%): -64.7270255210843
Buffett classification: The Gruesome
Stock price: 0.10294117647058824
Shares outstanding: 201883424
Book value: 4821074
P/B ratio: 4.31068205476012
Market cap (USD): 20782117.17647059
Debt to equity: 0.0291501437231621
Current ratio: 0.09732389358093074
Quick ratio: 0.09732389358093074
Interest coverage ratio: -196.69429892141756
Free cash flow (dilution-adjusted): -2436951
Buyback yield (%): 0
Retained earnings: -6542985
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -39.71768531244283
Rule of 40 score: 0
Financial ratios for EML.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -1945
Operating income: -2436414
Net income: -2519047
Capital expenditures: 5695233
Operating cash flow: -2265865
Depreciation & amortization: 1945
Net tangible assets: 12472351
Owner earnings: -8212335
Return on net tangible assets (%): -65.8443223735445
Buffett classification: The Gruesome
Stock price: 0.11363636363636363
Shares outstanding: 201883424
Book value: 12472351
P/B ratio: 1.839372399142566
Market cap (USD): 22941298.18181818
Debt to equity: 0.006716776973322832
Current ratio: 1.5146801987040708
Quick ratio: 1.5146801987040708
Interest coverage ratio: -153.32037002076646
Free cash flow (dilution-adjusted): -8389574
Buyback yield (%): 0
Retained earnings: -9852870
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.534520797241836
Rule of 40 score: 0
Financial ratios for EML.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.06666666666666667
Shares outstanding: 201883424
Market cap (USD): 13458894.933333334
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EML.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.04895104895104896
Shares outstanding: 201883424
Market cap (USD): 9882405.370629372
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EML.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -1911
Operating income: -1763067
Net income: -6912327
Capital expenditures: 655733
Operating cash flow: -1404572
Depreciation & amortization: 1911
Net tangible assets: 6146651
Owner earnings: -7566149
Return on net tangible assets (%): -123.09384411120787
Buffett classification: The Gruesome
Stock price: 0.04895104895104896
Shares outstanding: 201883424
Book value: 6146651
P/B ratio: 1.6077706983248883
Market cap (USD): 9882405.370629372
Debt to equity: 0
Current ratio: 0.2504184158336102
Quick ratio: 0.2504184158336102
Interest coverage ratio: -281.0564323290292
Free cash flow (dilution-adjusted): -2252101
Buyback yield (%): 0
Retained earnings: -16765197
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -28.68337571142399
Rule of 40 score: 0
Financial ratios for EML.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -259
Operating income: -344976
Net income: -350527
Capital expenditures: 29847
Operating cash flow: -152392
Depreciation & amortization: 259
Net tangible assets: 5830446
Owner earnings: -380115
Return on net tangible assets (%): -6.51948410121627
Buffett classification: The Gruesome
Stock price: 0.08391608391608392
Shares outstanding: 201883424
Book value: 5830446
P/B ratio: 2.9056553048686755
Market cap (USD): 16941266.34965035
Debt to equity: 0.008626441270530591
Current ratio: 0.1038057632265951
Quick ratio: 0.1038057632265951
Interest coverage ratio: -70.79335111840756
Free cash flow (dilution-adjusted): -216824
Buyback yield (%): 0
Retained earnings: -17115724
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.91680293411516
Rule of 40 score: 0
Financial ratios for EML.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -200
Operating income: -709373
Net income: -690211
Capital expenditures: 532540
Operating cash flow: -1024369
Depreciation & amortization: 200
Net tangible assets: 8056972
Owner earnings: -1222551
Return on net tangible assets (%): -15.173827090375887
Buffett classification: The Gruesome
Stock price: 0.0948905109489051
Shares outstanding: 201883424
Book value: 8056972
P/B ratio: 2.377670079463408
Market cap (USD): 19156821.255474452
Debt to equity: 0
Current ratio: 1.221601548227987
Quick ratio: 1.221601548227987
Interest coverage ratio: -199.26207865168539
Free cash flow (dilution-adjusted): -1579379
Buyback yield (%): 0
Retained earnings: -17805935
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.804461527233805
Rule of 40 score: 0
Financial ratios for EML.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -166
Operating income: -542234
Net income: -555532
Capital expenditures: 263712
Operating cash flow: -228211
Depreciation & amortization: 166
Net tangible assets: 8197436
Owner earnings: -819078
Return on net tangible assets (%): -9.991880387965214
Buffett classification: The Gruesome
Stock price: 0.2589928057553957
Shares outstanding: 201883424
Book value: 8197436
P/B ratio: 6.3783790952764
Market cap (USD): 52286354.41726619
Debt to equity: 0
Current ratio: 1.15661512810827
Quick ratio: 1.15661512810827
Interest coverage ratio: -182.6933962264151
Free cash flow (dilution-adjusted): -878860
Buyback yield (%): 0
Retained earnings: -18361467
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.614678052991203
Rule of 40 score: 0
Financial ratios for EML.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -163
Operating income: -769894
Net income: 2249242
Capital expenditures: 384654
Operating cash flow: -1159439
Depreciation & amortization: 163
Net tangible assets: 13350147
Owner earnings: 1864751
Return on net tangible assets (%): 13.968018479496894
Buffett classification: The Gruesome
Stock price: 0.2992700729927007
P/E ratio: 92.52719417753953
Shares outstanding: 201883424
Book value: 13350147
P/B ratio: 4.525618110159861
Market cap (USD): 60417667.03649634
Debt to equity: 0
Current ratio: 6.738366344160549
Quick ratio: 6.738366344160549
Interest coverage ratio: -1057.5467032967033
Free cash flow (dilution-adjusted): -1557665
Buyback yield (%): 0
Retained earnings: -16112225
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.766932753624361
Rule of 40 score: 0
Financial ratios for EML.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -788
Operating income: -2366477
Net income: 652972
Capital expenditures: 1210753
Operating cash flow: -2564411
Depreciation & amortization: 788
Net tangible assets: 13350147
Owner earnings: -556993
Return on net tangible assets (%): -4.172186268810373
Buffett classification: The Gruesome
Stock price: 0.2992700729927007
P/E ratio: 92.52719417753953
Shares outstanding: 201883424
Book value: 13350147
P/B ratio: 4.525618110159861
Market cap (USD): 60417667.03649634
Debt to equity: 0
Current ratio: 6.738366344160549
Quick ratio: 6.738366344160549
Interest coverage ratio: -195.10899497073132
Free cash flow (dilution-adjusted): -4232728
Buyback yield (%): 0
Retained earnings: -16112225
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.726224288017203
Rule of 40 score: 0
Financial ratios for EQNR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.28
Shares outstanding: 2376493265
Market cap (USD): 43442296884.200005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EQNR — annual report dated 2022-12-31
Total revenue: 15208704453.441294
Gross profit: 8988562753.036436
Operating income: 7868522267.206477
Net income: 2909514170.0404854
Capital expenditures: 886437246.9635627
Operating cash flow: 3556275303.6437244
Depreciation & amortization: 681477732.7935222
Net tangible assets: 5104149797.570849
Owner earnings: 2704554655.8704453
Return on net tangible assets (%): 52.987368379305565
Capex to operating income (%): 11.265612739738362
Buffett classification: The Great
Stock price: 26.1
P/E ratio: 21.318498756662496
Shares outstanding: 2376493265
Book value: 5464473684.2105255
P/B ratio: 11.350859716961235
Market cap (USD): 62026474216.5
Debt to equity: 0.5958065531867602
Current ratio: 1.7844310010272797
Quick ratio: 1.6656089487501424
Effective tax rate (%): 63.433158617882036
Interest coverage ratio: 83.68245425188374
COGS to revenue (%): 40.061359492087156
SG&A to revenue (%): 0.6561871930361636
Free cash flow (dilution-adjusted): 2669838056.680162
Buyback yield (%): 0.5409404936000997
Retained earnings: 5894331983.805668
Inventory turnover: 11.565225744476466
Receivables turnover: 6.692886731103291
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 68.06489458569727
FCF margin (%): 17.554671174348808
Rule of 40 score: 17.554671174348808
Financial ratios for EQNR — annual report dated 2023-12-31
Total revenue: 10495874263.261297
Gross profit: 4718958742.632613
Operating income: 3461001964.6365423
Net income: 1169351669.941061
Capital expenditures: 1038801571.7092339
Operating cash flow: 2873968565.8153243
Depreciation & amortization: 1039390962.6719058
Net tangible assets: 4317387033.398821
Owner earnings: 1169941060.9037328
Return on net tangible assets (%): 27.098359536756846
Capex to operating income (%): 30.01447506598927
Buffett classification: The Good
Stock price: 25.9
P/E ratio: 52.637010016501165
Shares outstanding: 2376493265
Book value: 4764243614.931238
P/B ratio: 12.919401386318142
Market cap (USD): 61551175563.5
Debt to equity: 0.6555670103092783
Current ratio: 1.7146725614810723
Quick ratio: 1.609284332688588
Effective tax rate (%): 68.57776369971492
Interest coverage ratio: 31.401960784313726
COGS to revenue (%): 55.0398697214735
SG&A to revenue (%): 1.139937106918239
Free cash flow (dilution-adjusted): 1835166994.1060903
Buyback yield (%): 0.8919694493283553
Retained earnings: 5552161100.196464
Inventory turnover: 15.419244887257472
Receivables turnover: 5.77431906614786
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 32.808455163423034
FCF margin (%): 17.484651093141657
Revenue growth (%): -30.98771630816731
Rule of 40 score: -13.503065215025654
Financial ratios for EQNR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.6
Shares outstanding: 2376493265
Market cap (USD): 53708747789
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EQNR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.76
Shares outstanding: 2376493265
Market cap (USD): 51712493446.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EQNR — annual report dated 2024-12-31
Total revenue: 9046954986.760813
Gross profit: 3762312444.8367167
Operating income: 2679082082.965578
Net income: 779258605.4721977
Capital expenditures: 1074757281.5533981
Operating cash flow: 1718005295.6751986
Depreciation & amortization: 874315975.286849
Net tangible assets: 3339364518.9761696
Owner earnings: 578817299.2056484
Return on net tangible assets (%): 17.333157129641858
Capex to operating income (%): 40.116623838703305
Buffett classification: The Good
Stock price: 21.76
P/E ratio: 66.36114517473237
Shares outstanding: 2376493265
Book value: 3740511915.2691975
P/B ratio: 13.824977601408966
Market cap (USD): 51712493446.4
Debt to equity: 0.710122699386503
Current ratio: 1.4756435863293387
Quick ratio: 1.3638204616067464
Effective tax rate (%): 71.50648680049055
Interest coverage ratio: 28.717123935666983
COGS to revenue (%): 58.41349437084153
SG&A to revenue (%): 1.2243663538272422
Free cash flow (dilution-adjusted): 643248014.1218005
Buyback yield (%): 1.0262798808993718
Retained earnings: 4625507502.206532
Inventory turnover: 14.853634333912181
Receivables turnover: 5.210023381112128
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.920330623705212
FCF margin (%): 7.1101051686796355
Revenue growth (%): -13.80465543086902
Rule of 40 score: -6.694550262189385
Financial ratios for EQNR — quarterly report dated 2025-03-31
Total revenue: 2803816793.89313
Gross profit: 1109828244.2748091
Operating income: 845515267.1755725
Net income: 250954198.47328243
Capital expenditures: 288835877.8625954
Operating cash flow: 862690839.6946565
Depreciation & amortization: 220419847.32824427
Net tangible assets: 3778339694.6564884
Owner earnings: 182538167.9389313
Return on net tangible assets (%): 4.831174078844357
Capex to operating income (%): 34.160929917616514
Buffett classification: The Good
Stock price: 24.67
P/E ratio: 58.405168357635375
Shares outstanding: 2376493265
Book value: 4376335877.862595
P/B ratio: 13.396615452693272
Market cap (USD): 58628088847.55
Debt to equity: 0.6490493633350778
Current ratio: 1.5355263528153755
Quick ratio: 1.4451979626867772
Effective tax rate (%): 70.42617789272462
Interest coverage ratio: 27.264615384615386
COGS to revenue (%): 60.417233868772115
SG&A to revenue (%): 1.0992376803702695
Free cash flow (dilution-adjusted): 573854961.832061
Buyback yield (%): 0.08935221531683142
Retained earnings: 5205152671.755725
Inventory turnover: 5.530529595015576
Receivables turnover: 1.5991292517006803
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.65678640862064
FCF margin (%): 20.46692077320991
Rule of 40 score: 20.46692077320991
Financial ratios for EQNR — quarterly report dated 2025-06-30
Total revenue: 2495531281.0327706
Gross profit: 890665342.6017874
Operating income: 567130089.3743793
Net income: 130784508.4409136
Capital expenditures: 337735849.0566038
Operating cash flow: 245978152.92949355
Depreciation & amortization: 340317775.57100296
Net tangible assets: 3530287984.1112213
Owner earnings: 133366434.95531279
Return on net tangible assets (%): 3.7777777777777772
Capex to operating income (%): 59.55174225179479
Buffett classification: The Good
Stock price: 23.82
P/E ratio: 148.290096201913
Shares outstanding: 2376493265
Book value: 4168023833.1678257
P/B ratio: 13.581512927500738
Market cap (USD): 56608069572.3
Debt to equity: 0.8182836176498618
Current ratio: 1.4657956623987458
Quick ratio: 1.3657434021426704
Effective tax rate (%): 77.11408230595589
Interest coverage ratio: 16.27065527065527
COGS to revenue (%): 64.30959013131715
SG&A to revenue (%): 1.3091922005571028
Free cash flow (dilution-adjusted): -91757696.12711023
Buyback yield (%): 0.046487699850060425
Retained earnings: 4887388282.025819
Inventory turnover: 4.220684251762862
Receivables turnover: 1.507950795079508
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.6644945001537375
FCF margin (%): -3.6768802228412256
Revenue growth (%): -10.995208871414935
Rule of 40 score: -14.67208909425616
Financial ratios for EQNR — quarterly report dated 2025-09-30
Total revenue: 2606913827.6553106
Gross profit: 882064128.256513
Operating income: 529659318.6372745
Net income: -20440881.763527054
Capital expenditures: 342685370.741483
Operating cash flow: 635871743.4869739
Depreciation & amortization: 337575150.3006012
Net tangible assets: 3417434869.7394786
Owner earnings: -25551102.204408824
Return on net tangible assets (%): -0.7476690318419049
Capex to operating income (%): 64.69920544835415
Buffett classification: The Good
Stock price: 23.45
P/E ratio: 154.24606290118106
Shares outstanding: 2376493265
Book value: 4067334669.3386765
P/B ratio: 13.701544523581372
Market cap (USD): 55728767064.25
Debt to equity: 0.7625640520299568
Current ratio: 1.4812963331155737
Quick ratio: 1.3751810719459199
Effective tax rate (%): 104.37205315045006
Interest coverage ratio: 14.442622950819672
COGS to revenue (%): 66.16443094899488
SG&A to revenue (%): 0.991659299688665
Free cash flow (dilution-adjusted): 293186372.74549097
Buyback yield (%): 0.8472182562962798
Retained earnings: 4804108216.432865
Inventory turnover: 4.607601713062098
Receivables turnover: 1.7759044368600683
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.252436928029889
FCF margin (%): 11.246492677864472
Revenue growth (%): 4.46327992235964
Rule of 40 score: 15.709772600224113